An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
Top Cited Papers
- 1 August 2011
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 80 (3), 282-287
- https://doi.org/10.1038/ki.2011.79
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- To eGFR or not to eGFR: here is an intern's answerKidney International, 2009
- Preventing Microalbuminuria in Type 2 DiabetesThe New England Journal of Medicine, 2004
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2001
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesThe New England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyThe New England Journal of Medicine, 2001
- The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)Journal of the Renin-Angiotensin-Aldosterone System, 2000
- A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal functionKidney International, 1997
- Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathyKidney International, 1995
- Renal protective effect of enalapril in diabetic nephropathy.BMJ, 1992
- Intraglomerular Hypertension: Implications and Drug TreatmentAnnual Review of Medicine, 1988